Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 4 , Pages 410-413 , December 2007

Factors Influencing the Postpartum Length of Hospital Stay in Eclamptic Women

,Accepted 11 June 2007.

References 

  1. ACOG Committee on Obstetric Practice  , ACOG practice bulletin  . Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists . Int J Gynaecol Obstet . 2002;77:67–75
  2. Cunningham FG , Gant NF , Leveno KJ , Gilstrap LC , Hauth JC , Wenstrom KD . Hypertensive disorders in pregnancy . In:  Cunningham FG ,  Gant NF ,  Leveno KJ ,  Gilstrap LC ,  Havth JC ,  Wenstrom KD editor. Williams Obstetrics . 21st edition. New York: McGraw-Hill; 2001;p. 567–618
  3. Mattar F , Sibai BM . Eclampsia. VIII. Risk factors for maternal morbidity . Am J Obstet Gynecol . 2000;182:307–312
  4. Lenfant C . Working group report on high blood pressure in pregnancy . J Clin Hypertens (Greenwich) . 2001;3:75–88
  5. Dildy GA , Cotton DB , Phelan JP . Complications of pregnancy-induced hypertension . In:  Clark SL ,  Cotton DB ,  Hankins GDV ,  Phelan JP editor. Critical Care Obstetrics . 2nd edition. Boston: Blackwell Scientific; 1991;p. 251–288
  6. Cunningham FG , Gant NF . Management of eclampsia . Semin Perinatol . 1994;18:103–113
  7. The Eclampsia Trial Collaborative Group . Which anti-convulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial . Lancet . 1995;345:1455–1463
  8. Isler CM , Barrilleaux PS , Rinehart BK , Magann EF , Martin JN . Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy . Obstet Gynecol . 2003;101:66–69
  9. Ascarelli MH , Johnson V , May WL , Martin RW , Martin JN . Individually determined postpartum magnesium sulfate therapy with clinical parameters to safely and cost-effectively shorten treatment for pre-eclampsia . Am J Obstet Gynecol . 1998;179:952–956
  10. Fontenot MT, Lewis DF, Frederick JB, Wang Y, DeFranco EA, Groome LJ, et al. A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of post-partum therapy . Am J Obstet Gynecol . 2005;192:1788–1793 discussion 1793-4.
  11. Duley L . Evidence and practice: the magnesium sulphate story . Best Pract Res Clin Obstet Gynaecol . 2005;19:57–74
  12. Ekele BA , Ahmed Y . Magnesium sulfate regimens for eclampsia . Int J Gynaecol Obstet . 2004;87:149–150
  13. Vigil-De Gracia P , Garcia-Caceres E . Thrombocytopenia, hypertension and seizures in eclampsia . Int J Gynaecol Obstet . 1998;61:15–20
  14. Usta IM , Sibai BM . Emergent management of puerperal eclampsia . Obstet Gynecol Clin North Am . 1995;22:315–335
  15. Haddad B , Barton JR , Livingston JC , Chahine R , Sibai BM . Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome . Am J Obstet Gynecol . 2000;183:444–448

PII: S1028-4559(08)60012-1

doi: 10.1016/S1028-4559(08)60012-1

Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 4 , Pages 410-413 , December 2007

Article Tools